Latest news

• UK government announce £260m to boost healthcare research and manufacturing

  NHS data through digital clinical trial services and Trusted Research Environments. ... This includes the RECOVERY trial which made use of NHS data through NHS DigiTrials and led to the discovery of Dexamethasone, the world’s first proven treatment for

• Results from trial show Eli Lilly’s COVID-19 drug improves survival rates

  The RECOVERY trial is the biggest study of COVID-19 treatments in the world, involving more than 47, 000 participants in the UK. ... Since March 2020, the RECOVERY trial has tested a variety of potential therapies for patients admitted to hospital with

• Roche’s Actemra approved for severe COVID-19 in Europe

  The COVID-19 indication is based on extensive data from four major trials, including the University of Oxford’s RECOVERY trial, the phase 3 study that looked at whether several potential

• FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19

  The phase 3 trial evaluated REGEN-COV (casirivimab with imdevimab) in 4, 567 high-risk outpatients with COVID-19. ... In June, the UK-based RECOVERY trial showed REGEN-COV improved survival in hospitalised COVID-19 patients who lack an immune response to

• US orders 1.4 million more doses of Regeneron antibody cocktail

  infection, including the UK RECOVERY trial.